发明授权
US08853150B2 Chimeric IL-1 receptor type I antagonists 有权
嵌合IL-1受体I型拮抗剂

Chimeric IL-1 receptor type I antagonists
摘要:
Featured herein are non-naturally occurring cytokine domains that can be used, inter alia, to modulate cellular signalling responsive to interleukin-1 receptor I (IL-1 RI), to treat disorders, and to detect and/or bind to cellular receptors, as well as other agents. Exemplary cytokine domains can contain amino acid residues from at least two parental cytokines domains, for example, receptor binding features, surface features, β strands, and loops from at least two parental cytokines domains.
公开/授权文献
信息查询
0/0